• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    Healthcare

    Cummings: EpiPen CEO raised prices to get ‘filthy rich’

    Robert King -
    September 21, 2016 7:40 pm
    0
    Mylan acquired the patent for EpiPen in 2007, becoming the sole seller and marketer of this life-saving medication. (Daniel Acker/Bloomberg)
    Healthcare

    Washington’s monopoly policy

    Deane Waldman -
    September 15, 2016 1:23 pm
    0
    Martin Shkreli tweeted his demand on the same day the House Oversight and Government Reform Committee announced a Sept. 21 hearing to scrutinize the price increase of allergy treatment EpiPens. (AP Photo)
    Healthcare

    Pharma’s Shkreli wants immunity to testify to Congress

    Robert King -
    September 14, 2016 7:19 pm
    0
    GAO finds that 300 generic drugs had at least one price hike of 100 percent or more since 2010. (AP Photo/Matt Rourke)
    Healthcare

    Senators lament spikes in generic drugs

    Robert King -
    September 14, 2016 6:43 pm
    0
    Agency has approved three competitors, but doesn't regulate prices, official says. (AP Photo/Jose Luis Magana)
    Healthcare

    FDA defends itself from EpiPen critics

    Robert King -
    September 14, 2016 4:53 pm
    0
    The House Oversight Committee's Sept. 21 hearing will include testimony from Mylan CEO Heather Bresch on the high price tag of $600 for EpiPens. (iStock photo)
    Healthcare

    House panel to hold hearing over EpiPen price hikes

    Robert King -
    September 14, 2016 1:50 pm
    0
    Sen. Chuck Grassley blasted Mylan for insufficient answers to a series of questions he gave the drug maker about the EpiPen price hike. (AP Photo/J. Scott Applewhite)
    Healthcare

    Do better, Grassley tells EpiPen maker

    Robert King -
    September 9, 2016 6:51 pm
    0
    Costly new drugs do extend the lives of patients significantly, a new study finds. (iStock Photo)
    Healthcare

    Study: Expensive cancer drugs are worth it

    Paige Winfield Cunningham -
    September 7, 2016 8:00 pm
    0
    The Permanent Subcommittee on Investigations will look into Mylan's pricing and competition practices. (AP Photo/Alex Brandon)
    Healthcare

    Senate starts investigation into EpiPen price hikes

    Robert King -
    September 7, 2016 7:31 pm
    0
    Democratic presidential candidate Hillary Clinton said the recent news that EpiPen maker Mylan hiked prices by 500 percent shows the government needs stronger tools to crack down on pharmaceutical companies. (AP Photo/Carolyn Kaster)
    Healthcare

    Clinton plan goes after price-hiking drug makers

    Paige Winfield Cunningham -
    September 2, 2016 2:02 pm
    0
    1...118119120...157Page 119 of 157
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.